Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 06, 2026 07:16 ET | Source: Bright Minds Biosciences

Bright Minds Biosciences Announces Positive Topline Results from Phase 2 Clinical Trial of BMB-101 in Patients with Absence Seizures and Developmental and Encephalopathic Epilepsies (DEE)

BMB-101 demonstrated significant anti-seizure benefit in both cohorts with favorable safety and tolerability Absence: 73.1% median reduction in the number of absence seizure ≥3s, p = 0.012DEE: 63.3%...
January 06, 2026 07:15 ET | Source: Alvotech

Alvotech announces planned CEO succession and leadership transition

- Róbert Wessman to continue serving as Executive Chairman in full-time capacity - Lisa Graver appointed Chief Executive Officer REYKJAVIK, Iceland, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Alvotech...
January 06, 2026 07:15 ET | Source: Alvotech

Alvotech tilkynnir breytingar á yfirstjórn félagsins

Róbert Wessman heldur áfram sem starfandi stjórnarformaðurLisa Graver tekur við stöðu forstjóra Alvotech (NASDAQ: ALVO, ALVO SDB) tilkynnti í dag breytingar á yfirstjórn félagsins sem eru fram undan...
January 06, 2026 07:15 ET | Source: Alvotech

Alvotech announces planned CEO succession and leadership transition

Róbert Wessman to continue serving as Executive Chairman in full-time capacityLisa Graver appointed Chief Executive Officer REYKJAVIK, ICELAND (January 6, 2026) — Alvotech (NASDAQ: ALVO), a global...
January 06, 2026 07:05 ET | Source: Cartesian Therapeutics, Inc.

Cartesian Therapeutics Announces New Employment Inducement Grants

FREDERICK, Md., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases,...
January 06, 2026 07:01 ET | Source: BioCryst Pharmaceuticals, Inc.

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

RESEARCH TRIANGLE PARK, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted...
January 06, 2026 07:00 ET | Source: Tilray Brands, Inc.

Tilray Brands Expands Dry January Offerings with Zero-Proof Spirits, Non-Alcoholic Beers and Hemp-Derived THC Beverages

NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and...
January 06, 2026 07:00 ET | Source: BioCryst Pharmaceuticals, Inc.

BioCryst to Present at 44th Annual J.P. Morgan Healthcare Conference

RESEARCH TRIANGLE PARK, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the 44th Annual J.P. Morgan...
January 06, 2026 07:00 ET | Source: Plug Power, Inc.

Plug to Participate in Goldman Sachs Energy, CleanTech & Utilities Conference

SLINGERLANDS, N.Y., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the hydrogen economy, announce its participation in...
January 06, 2026 07:00 ET | Source: Lantronix, Inc.

Lantronix Redefines Integrated Edge Intelligence With AI-Powered Surveillance Ecosystem and Real-Time Video Analytics

LAS VEGAS, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), a global leader in compute and connectivity IoT solutions powering Edge AI applications, today announced the debut of its...